GH1 and hepatocellular carcinoma: Previous studies have demonstrated that hGH activates janus kinase (JAK)/STAT signaling pathways in mammary and endometrial cancer cells [13,15], as well as in the HCC cell lines Bel-7404 and HepG2 [20].